Expression of DDX27 contributes to colony-forming ability of gastric cancer cells and correlates with poor prognosis in gastric cancer

American Journal of Cancer Research

Volumn 5, Issue 10, 2015, Pages 2998-3014

  Tsukamoto, Yoshiyuki ^a   Fumoto, Shoichi ^a   Noguchi, Tsuyoshi ^b   Yanagihara, Kazuyoshi ^c   Hirashita, Yuka ^a   Nakada, Chisato ^a   Hijiya, Naoki ^a   Uchida, Tomohisa ^a   Matsuura, Keiko ^a   Hamanaka, Ryoji ^a   Murakami, Kazunari ^a   Seto, Masao ^d   Inomata, Masafumi ^a   Moriyama, Masatsugu ^a  

^a OITA UNIVERSITY   (Japan)

^b Faculty of Medicine   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

20q13; Colony formation; DDX27; Gastric cancer; RNA helicase

Indexed keywords

PROTEIN P53;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOASSAY; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL VIABILITY; CHROMOSOME 20Q; CLINICAL FEATURE; CONTROLLED STUDY; DDX27 GENE; FEMALE; GASTRIC CANCER CELL LINE; GENE DOSAGE; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; ONCOGENE; STOMACH CANCER; TISSUE SECTION; TUMOR INVASION; UPREGULATION;

EID: 84964992605     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, Tanigawa M, Takeuchi I, Matsuura K, Hijiya N, Nakada C, Kishida T, Kawahara K, Ito H, Murakami K, Fujioka T, Seto M and Moriyama M. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 2008; 216: 471-482.
2. Carvalho B, Buffart TE, Reis RM, Mons T, Moutinho C, Silva P, van Grieken NC, Grabsch H, van de Velde CJ, Ylstra B, Meijer GA and Carneiro F. Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol 2006; 28: 283-294.
3. Kimura Y, Noguchi T, Kawahara K, Kashima K, Daa T and Yokoyama S. Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Mod Pathol 2004; 17: 1328-1337.
4. Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapiainen R, Kivilaakso E and Knuutila S. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet 1998; 107: 32-36.
5. Noguchi T, Wirtz HC, Michaelis S, Gabbert HE and Mueller W. Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001; 115: 828-834.
6. Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, Mochizuki H, Okanoue T and Inazawa J. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005; 96: 100-110.
7. Fan B, Dachrut S, Coral H, Yuen ST, Chu KM, Law S, Zhang L, Ji J, Leung SY and Chen X. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer. PLoS One 2012; 7: e29824.
8. Hidaka S, Yasutake T, Kondo M, Takeshita H, Yano H, Haseba M, Tsuji T, Sawai T, Nakagoe T and Tagawa Y. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. Anticancer Res 2003; 23: 3353-3357.
9. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M and Murty VV. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 2008; 47: 755-765.
10. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M and Testa JR. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 1997; 20: 320-328.
11. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, Domany E and Notterman DA. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006; 66: 2129-2137.
12. Hodgson JG, Chin K, Collins C and Gray JW. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 2003; 78: 337-345.
13. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van Der Kwast TT, Schroder FH, Tanke HJ and van Dekken H. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features. Am J Pathol 2001; 158: 399-406.
14. Mahlamaki EH, Barlund M, Tanner M, Gorunova L, Hoglund M, Karhu R and Kallioniemi A. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 2002; 35: 353-358.
15. Nancarrow DJ, Handoko HY, Smithers BM, Gotley DC, Drew PA, Watson DI, Clouston AD, Hayward NK and Whiteman DC. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res 2008; 68: 4163-4172.
16. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP and Knowles MA. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004; 23: 2250-2263.
17. Tabach Y, Kogan-Sakin I, Buganim Y, Solomon H, Goldfinger N, Hovland R, Ke XS, Oyan AM, Kalland KH, Rotter V and Domany E. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS One 2011; 6: e14632.
18. van Dekken H, Paris PL, Albertson DG, Alers JC, Andaya A, Kowbel D, van der Kwast TH, Pinkel D, Schroder FH, Vissers KJ, Wildhagen MF and Collins C. Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis. Genes Chromosomes Cancer 2004; 39: 249-256.
19. Postma C, Terwischa S, Hermsen MA, van der Sijp JR and Meijer GA. Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Cell Oncol 2007; 29: 73-75.
20. Hirasaki S, Noguchi T, Mimori K, Onuki J, Morita K, Inoue H, Sugihara K, Mori M and Hirano T. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study. Oncologist 2007; 12: 406-417.
21. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC Jr, James CD, Couch FJ, Hartmann LC, Lillie J and Smith DI. Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res 2001; 61: 5895-5904.
22. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, van Criekinge W, Thas O, Matthai A, Cuesta MA, Terhaar Sive Droste JS, Craanen M, Schrock E, Ylstra B and Meijer GA. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009; 58: 79-89.
23. Uchida M, Tsukamoto Y, Uchida T, Ishikawa Y, Nagai T, Hijiya N, Nguyen LT, Nakada C, Kuroda A, Okimoto T, Kodama M, Murakami K, Noguchi T, Matsuura K, Tanigawa M, Seto M, Ito H, Fujioka T, Takeuchi I and Moriyama M. Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol 2010; 221: 96-105.
24. Bruin SC, Klijn C, Liefers GJ, Braaf LM, Joosse SA, van Beers EH, Verwaal VJ, Morreau H, Wessels LF, van Velthuysen ML, Tollenaar RA and Van't Veer LJ. Specific genomic aberrations in primary colorectal cancer are associated with liver metastases. BMC Cancer 2010; 10: 662.
25. Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, Sawai T, Yamaguchi H, Nakagoe T, Ayabe H and Tagawa Y. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-2717.
26. Fujita Y, Sakakura C, Shimomura K, Nakanishi M, Yasuoka R, Aragane H, Hagiwara A, Abe T, Inazawa J and Yamagishi H. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 2003; 50: 1857-1863.
27. Sillars-Hardebol AH, Carvalho B, Tijssen M, Belien JA, de Wit M, Delis-van Diemen PM, Ponten F, van de Wiel MA, Fijneman RJ and Meijer GA. TPX2 and AURKA promote 20q amplicondriven colorectal adenoma to carcinoma progression. Gut 2012; 61: 1568-1575.
28. Littlepage LE, Adler AS, Kouros-Mehr H, Huang G, Chou J, Krig SR, Griffith OL, Korkola JE, Qu K, Lawson DA, Xue Q, Sternlicht MD, Dijkgraaf GJ, Yaswen P, Rugo HS, Sweeney CA, Collins CC, Gray JW, Chang HY and Werb Z. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer Discov 2012; 2: 638-651.
29. Jang SH, Park JW, Kim HR, Seong JK and Kim HK. ADRM1 gene amplification is a candidate driver for metastatic gastric cancers. Clin Exp Metastasis 2014; 31: 727-733.
30. Jarmoskaite I and Russell R. DEAD-box proteins as RNA helicases and chaperones. Wiley Interdiscip Rev RNA 2011; 2: 135-152.
31. Parsyan A, Shahbazian D, Martineau Y, Petroulakis E, Alain T, Larsson O, Mathonnet G, Tettweiler G, Hellen CU, Pestova TV, Svitkin YV and Sonenberg N. The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Proc Natl Acad Sci U S A 2009; 106: 22217-22222.
32. Mazurek A, Luo W, Krasnitz A, Hicks J, Powers RS and Stillman B. DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov 2012; 2: 812-825.
33. Fukawa T, Ono M, Matsuo T, Uehara H, Miki T, Nakamura Y, Kanayama HO and Katagiri T. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas. Cancer Res 2012; 72: 5867-5877.
34. Zhou J, Yong WP, Yap CS, Vijayaraghavan A, Sinha RA, Singh BK, Xiu S, Manesh S, Ngo A, Lim A, Ang C, Xie C, Wong FY, Lin SJ, Wan WK, Tan I, Flotow H, Tan P, Lim KH, Yen PM and Goh LK. An Integrative Approach Identified Genes Associated with Drug Response in Gastric Cancer. Carcinogenesis 2015; 36: 441-51.
35. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1998; 1: 10-24.
36. Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
37. Yanagihara K, Ito A, Toge T and Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993; 53: 5815-5821.
38. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y and Hirohashi S. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 2005; 96: 323-332.
39. Moriyama M, Tsukamoto Y, Fujiwara M, Kondo G, Nakada C, Baba T, Ishiguro N, Miyazaki A, Nakamura K, Hori N, Sato K, Shomori K, Takeuchi K, Satoh H, Mori S and Ito H. Identification of a novel human ankyrin-repeated protein homologous to CARP. Biochem Biophys Res Commun 2001; 285: 715-723.
40. Matsuo M, Nakada C, Tsukamoto Y, Noguchi T, Uchida T, Hijiya N, Matsuura K and Moriyama M. MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2. Mol Cancer 2013; 12: 15.
41. Cui C and Tseng H. Estimation of ribosomal RNA transcription rate in situ. Biotechniques 2004; 36: 134-138.
42. Valastyan S and Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292.
43. Hicks GG, Egan SE, Greenberg AH and Mowat M. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest. Mol Cell Biol 1991; 11: 1344-1352.
44. Wagner AJ, Small MB and Hay N. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol 1993; 13: 2432-2440.
45. Zhu Q, Yasumoto H and Tsai RY. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol 2006; 26: 9279-9290.
46. Hernandez-Verdun D. The nucleolus: a model for the organization of nuclear functions. Histochem Cell Biol 2006; 126: 135-148.
47. Boulon S, Westman BJ, Hutten S, Boisvert FM and Lamond AI. The nucleolus under stress. Mol Cell 2010; 40: 216-227.
48. Chaffer CL and Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331: 1559-1564.
49. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A and Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000; 6: 100-102.
50. Cheung KJ and Ewald AJ. Illuminating breast cancer invasion: diverse roles for cell-cell interactions. Curr Opin Cell Biol 2014; 30: 99-111.
51. Ripmaster TL, Vaughn GP and Woolford JL Jr. A putative ATP-dependent RNA helicase involved in Saccharomyces cerevisiae ribosome assembly. Proc Natl Acad Sci U S A 1992; 89: 11131-11135.
52. Zhang Y and Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16: 369-377.
53. Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K, Itoh B, Wang J, Komatsu Y, Yang YR, Hikasa H, Horie Y, Yamashita T, Kamijo T, Zhang Y, Zhu Y, Prives C, Nakano T, Mak TW, Sasaki T, Maehama T, Mori M and Suzuki A. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med 2011; 17: 944-951.